Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

21462-39-5

Clindamycin HCl

21462-39-5
483-63-6

Crotamiton

483-63-6
302-22-7

Chlormadinone Acetate

302-22-7
57808-65-8

Closantel

57808-65-8
120-32-1

Chlorophene

120-32-1
54239-37-1

Cimaterol

54239-37-1
53994-73-3

Cefaclor

53994-73-3
69-09-0

Chlorpromazine HCl

69-09-0
2446-23-3

4-Chlorodehydromethyltestosterone

2446-23-3
226256-56-0

Cinacalcet

226256-56-0
50-14-6

Calciferol - Vitamin D2

50-14-6
05/07/6804

Carbadox

05/07/6804
57-62-5

Chlortetracycline

57-62-5
23239-41-0

Cefacetrile sodium

23239-41-0
56-89-3

L-(-)-Cystine

56-89-3
15663-27-1

Cisplatin

15663-27-1
120202-66-6

(S)-(+)-Clopidogrel hydrogensulfate

120202-66-6
17321-77-6

Clomipramine HCl

17321-77-6
113826-44-1

Cefoperazone 2H2O

113826-44-1
7084-24-4

Cyanidin 3-O-glucoside chloride

7084-24-4